| Identification | Back Directory | [Name]
1-Propanaminium, N-(3-aminopropyl)-N,N-dimethyl-2,3-bis[(9Z)-9-tetradecen-1-yloxy]-, bromide (1:1), mixt. with 1,1'-[(1R)-1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl] bis(3,7,11,15-tetramethylhexadecanoate) | [CAS]
370108-99-9 | [Synonyms]
Vaxfectin
1-Propanaminium, N-(3-aminopropyl)-N,N-dimethyl-2,3-bis[(9Z)-9-tetradecen-1-yloxy]-, bromide (1:1), mixt. with 1,1'-[(1R)-1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl] bis(3,7,11,15-tetramethylhexadecanoate) | [Molecular Formula]
C81H163BrN3O10P | [MOL File]
370108-99-9.mol | [Molecular Weight]
1450.08 |
| Hazard Information | Back Directory | [Uses]
Vaxfectin is a cationic lipid-based adjuvant that can be used for plasmid DNA- and protein-based vaccines[1]. | [References]
[1] Sullivan SM, et, al. Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines. Expert Opin Drug Deliv. 2010 Dec;7(12):1433-46. DOI:10.1517/17425247.2010.538047 |
|
|